We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $23.2B
1-Year Est. Return 40.19%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+40.19%
3 Year Est. Return
+109.35%
5 Year Est. Return
+140.11%
10 Year Est. Return
+481.97%
AUM
$52B
AUM Growth
+$1.06B
Cap. Flow
-$509M
Cap. Flow %
-0.98%
Top 10 Hldgs %
14.74%
Holding
1,623
New
75
Increased
581
Reduced
580
Closed
84

Sector Composition

Rank Sector Weight
1 Healthcare 18.11%
2 Financials 13.87%
3 Technology 12.03%
4 Energy 10.84%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STE icon
201
Steris
STE
$21.9B
$43.9M 0.08%
600,901
+26,223
+5% +$1.85M
FMBI
202
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$43.8M 0.08%
2,262,451
-10,712
-0.5% -$203K
ALGN icon
203
Align Technology
ALGN
$11.3B
$43.8M 0.08%
467,074
+340,728
+270% +$30.8M
OUT icon
204
Outfront Media
OUT
$5.1B
$43.4M 0.08%
1,865,362
-1,768,722
-49% -$39.8M
AVB
205
DELISTED
AvalonBay Communities
AVB
$43.3M 0.08%
243,633
+442
+0.2% +$79.5K
PBR icon
206
Petrobras
PBR
$130B
$43.1M 0.08%
4,623,558
-56,200
-1% -$493K
MTH icon
207
Meritage Homes
MTH
$4.39B
$43.1M 0.08%
2,481,724
-18,422
-0.7% -$335K
VNO icon
208
Vornado Realty Trust
VNO
$6.83B
$42.8M 0.08%
522,514
-34,475
-6% -$2.86M
WERN icon
209
Werner Enterprises
WERN
$2.4B
$42.7M 0.08%
1,835,727
+155,381
+9% +$3.69M
CLB icon
210
Core Laboratories
CLB
$575M
$42.6M 0.08%
378,750
-384,416
-50% -$44.3M
BMY icon
211
Bristol-Myers Squibb
BMY
$136B
$42.5M 0.08%
788,455
-184,444
-19% -$11.8M
PF
212
DELISTED
Pinnacle Foods, Inc.
PF
$42.3M 0.08%
843,769
-3,490
-0.4% -$173K
TMO icon
213
Thermo Fisher Scientific
TMO
$227B
$42.3M 0.08%
265,903
-20,725
-7% -$3.19M
LII icon
214
Lennox International
LII
$13.5B
$42M 0.08%
267,643
+251,357
+1,543% +$39.1M
AIV
215
Aimco
AIV
$372M
$42M 0.08%
6,869,236
+1,013,463
+17% +$6.1M
NTCT icon
216
NETSCOUT
NTCT
$2.71B
$41.9M 0.08%
1,434,141
-5,161
-0.4% -$142K
WFC icon
217
Wells Fargo
WFC
$272B
$41.9M 0.08%
946,935
+281,618
+42% +$13.5M
CRUS icon
218
Cirrus Logic
CRUS
$5.67B
$41.4M 0.08%
779,439
-292,632
-27% -$14.1M
ACH
219
Accendra Health
ACH
$93.1M
$41.4M 0.08%
1,192,403
-55,631
-4% -$1.95M
BETR
220
DELISTED
Amplify Snack Brands, Inc.
BETR
$41.1M 0.08%
2,534,226
+2,393,820
+1,705% +$37.5M
TEVA icon
221
Teva Pharmaceuticals
TEVA
$42.4B
$41M 0.08%
890,203
-89,843
-9% -$4.69M
TREX icon
222
Trex
TREX
$4.65B
$40.8M 0.08%
2,779,680
+2,499,312
+891% +$34.9M
GGG icon
223
Graco
GGG
$12.6B
$40.8M 0.08%
1,652,634
-2,309,520
-58% -$57.8M
QTS
224
DELISTED
QTS REALTY TRUST, INC.
QTS
$40.7M 0.08%
770,804
+716,217
+1,312% +$39.2M
SPLK
225
DELISTED
Splunk Inc
SPLK
$40.7M 0.08%
692,789
+648,792
+1,475% +$38.9M

Similar funds

Macquarie Group's Q3 2016 Portfolio in Review

As of Q3 2016, Macquarie Group held 1,623 positions worth $52B, up 2.1% from $50.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q3 2016 filing shows 75 new, 581 increased, 580 reduced and 84 closed positions. Its largest new stake was VEON: 320,544 shares worth $27.9M. The largest sale was Johnson Controls International, an estimated $702M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q3 2016 buy was VEON: 320,544 shares worth $27.9M.
  • Macquarie Group added most to Abbott in Q3 2016, an estimated $736M increase.
  • Macquarie Group's biggest Q3 2016 reduction was Johnson Controls International, cutting an estimated $702M.
  • Macquarie Group fully exited UBS Group in Q3 2016, selling an estimated $46.3M.
  • Macquarie Group's ten largest holdings make up 15% of its $52B portfolio in Q3 2016.
  • Macquarie Group opened 75 new positions and closed 84 in Q3 2016.
  • Macquarie Group's portfolio value rose 2.1% quarter-over-quarter to $52B.

Based on Macquarie Group's 13F filing for Q3 2016, filed 15 Nov 2016.